BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30421112)

  • 1. In Vitro Anti-hepatitis B Virus Activity of 2',3'-Dideoxyguanosine.
    Zhang P; Zhai S; Chang J; Guo JT
    Virol Sin; 2018 Dec; 33(6):538-544. PubMed ID: 30421112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro characterization of the anti-hepatitis B virus activity and cross-resistance profile of 2',3'-dideoxy-3'-fluoroguanosine.
    Jacquard AC; Brunelle MN; Pichoud C; Durantel D; Carrouée-Durantel S; Trepo C; Zoulim F
    Antimicrob Agents Chemother; 2006 Mar; 50(3):955-61. PubMed ID: 16495257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfamoylbenzamide derivatives inhibit the assembly of hepatitis B virus nucleocapsids.
    Campagna MR; Liu F; Mao R; Mills C; Cai D; Guo F; Zhao X; Ye H; Cuconati A; Guo H; Chang J; Xu X; Block TM; Guo JT
    J Virol; 2013 Jun; 87(12):6931-42. PubMed ID: 23576513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human and duck hepatitis B virus by 2',3'-dideoxy-3'-fluoroguanosine in vitro.
    Schröder I; Holmgren B; Oberg M; Löfgren B
    Antiviral Res; 1998 Jan; 37(1):57-66. PubMed ID: 9497073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isothiafludine, a novel non-nucleoside compound, inhibits hepatitis B virus replication through blocking pregenomic RNA encapsidation.
    Yang L; Shi LP; Chen HJ; Tong XK; Wang GF; Zhang YM; Wang WL; Feng CL; He PL; Zhu FH; Hao YH; Wang BJ; Yang DL; Tang W; Nan FJ; Zuo JP
    Acta Pharmacol Sin; 2014 Mar; 35(3):410-8. PubMed ID: 24487969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of novel hepadnaviral RNA species accumulated in hepatoma cells treated with viral DNA polymerase inhibitors.
    Zhang P; Liu F; Guo F; Zhao Q; Chang J; Guo JT
    Antiviral Res; 2016 Jul; 131():40-8. PubMed ID: 27083116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro inhibition of hepadnavirus polymerases by the triphosphates of BMS-200475 and lobucavir.
    Seifer M; Hamatake RK; Colonno RJ; Standring DN
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3200-8. PubMed ID: 9835515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral activity of various 1-(2'-deoxy-β-D-lyxofuranosyl), 1-(2'-fluoro-β-D-xylofuranosyl), 1-(3'-fluoro-β-D-arabinofuranosyl), and 2'-fluoro-2',3'-didehydro-2',3'-dideoxyribose pyrimidine nucleoside analogues against duck hepatitis B virus (DHBV) and human hepatitis B virus (HBV) replication.
    Srivastav NC; Shakya N; Mak M; Agrawal B; Tyrrell DL; Kumar R
    J Med Chem; 2010 Oct; 53(19):7156-66. PubMed ID: 20857959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal models for the study of HBV infection and the evaluation of new anti-HBV strategies.
    Zoulim F; Berthillon P; Guerhier FL; Seigneres B; Germon S; Pichoud C; Cheng YC; Trepo C
    J Gastroenterol Hepatol; 2002 Dec; 17 Suppl():S460-3. PubMed ID: 12534778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver-targeted antiviral nucleosides: enhanced antiviral activity of phosphatidyl-dideoxyguanosine versus dideoxyguanosine in woodchuck hepatitis virus infection in vivo.
    Korba BA; Xie H; Wright KN; Hornbuckle WE; Gerin JL; Tennant BC; Hostetler KY
    Hepatology; 1996 May; 23(5):958-63. PubMed ID: 8621175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral activity of clevudine [L-FMAU, (1-(2-fluoro-5-methyl-beta, L-arabinofuranosyl) uracil)] against woodchuck hepatitis virus replication and gene expression in chronically infected woodchucks (Marmota monax).
    Peek SF; Cote PJ; Jacob JR; Toshkov IA; Hornbuckle WE; Baldwin BH; Wells FV; Chu CK; Gerin JL; Tennant BC; Korba BE
    Hepatology; 2001 Jan; 33(1):254-66. PubMed ID: 11124844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonistic Activation of Cytosolic DNA Sensing Receptors in Woodchuck Hepatocyte Cultures and Liver for Inducing Antiviral Effects.
    Suresh M; Li B; Huang X; Korolowicz KE; Murreddu MG; Gudima SO; Menne S
    Front Immunol; 2021; 12():745802. PubMed ID: 34671360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The main hepatitis B virus (HBV) mutants resistant to nucleoside analogs are susceptible in vitro to non-nucleoside inhibitors of HBV replication.
    Billioud G; Pichoud C; Puerstinger G; Neyts J; Zoulim F
    Antiviral Res; 2011 Nov; 92(2):271-6. PubMed ID: 21871497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of duck hepatitis B virus replication in vitro by 2',3'-dideoxy-3'-azidothymidine and related compounds.
    Suzuki S; Lorne D; Tyrrell J; Saneyoshi M
    Acta Virol; 1991 Sep; 35(5):430-7. PubMed ID: 1688076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives for the treatment of hepatitis B virus infections.
    De Clercq E
    Int J Antimicrob Agents; 1999 Jul; 12(2):81-95. PubMed ID: 10418752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and biological evaluation of new 1,2,3-triazolo-2'-deoxy-2'-fluoro- 4'-azido nucleoside derivatives as potent anti-HBV agents.
    Liu Y; Peng Y; Lu J; Wang J; Ma H; Song C; Liu B; Qiao Y; Yu W; Wu J; Chang J
    Eur J Med Chem; 2018 Jan; 143():137-149. PubMed ID: 29174810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral effects of lamivudine, emtricitabine, adefovir dipivoxil, and tenofovir disoproxil fumarate administered orally alone and in combination to woodchucks with chronic woodchuck hepatitis virus infection.
    Menne S; Butler SD; George AL; Tochkov IA; Zhu Y; Xiong S; Gerin JL; Cote PJ; Tennant BC
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3617-32. PubMed ID: 18676881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleic acid polymers inhibit duck hepatitis B virus infection in vitro.
    Noordeen F; Vaillant A; Jilbert AR
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5291-8. PubMed ID: 23939902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the conserved woodchuck hepatitis virus polymerase FLLA and YMDD regions conferring resistance to lamivudine.
    Tatti KM; Korba BE; Stang HL; Peek S; Gerin JL; Tennant BC; Schinazi RF
    Antiviral Res; 2002 Jul; 55(1):141-50. PubMed ID: 12076758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B Virus Capsid Assembly Modulators, but Not Nucleoside Analogs, Inhibit the Production of Extracellular Pregenomic RNA and Spliced RNA Variants.
    Lam AM; Ren S; Espiritu C; Kelly M; Lau V; Zheng L; Hartman GD; Flores OA; Klumpp K
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.